We are live on
!
Find out more
MPA
Marvin & Palmer Associates Portfolio holdings
AUM
$83.5M
1-Year Est. Return
77.51%
This Fund
S&P 500
This Quarter
Est. Return
-7.03%
1 Year Est. Return
+77.51%
3 Year Est. Return
+274.35%
5 Year Est. Return
+527.21%
10 Year Est. Return
+3,503.66%
AUM
$116M
AUM Growth
-$15.8M
(-12%)
Cap. Flow
-$5.49M
Cap. Flow
% of AUM
-4.73%
Top 10 Holdings %
Top 10 Hldgs %
51.85%
Holding
36
New
10
Increased
14
Reduced
3
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$4.9M |
| 2 |
Eli Lilly
LLY
|
+$4.86M |
| 3 |
Walt Disney
DIS
|
+$4.84M |
| 4 |
Pfizer
PFE
|
+$4.82M |
| 5 |
Ecolab
ECL
|
+$4.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
+$8.77M |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$7.16M |
| 3 |
State Street SPDR S&P Retail ETF
XRT
|
+$6.07M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$5.17M |
| 5 |
Amphenol
APH
|
+$4.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.23% |
| 2 | Healthcare | 21.71% |
| 3 | Technology | 15.94% |
| 4 | Consumer Discretionary | 6.48% |
| 5 | Communication Services | 4.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
VanEck Vietnam ETF
VNM
$504M
| $937K | 0.81% |
63,499
+15,970
| +34% | +$247K |
|
27
SPDR Gold Trust
GLD
$138B
| $922K | 0.79% |
+7,600
| New | +$883K |
|
|
28
Amphenol
APH
$210B
| – | – |
-193,820
| Closed | -$4.56M |
|
|
29
iShares Core S&P Small-Cap ETF
IJR
$111B
| – | – |
-100,566
| Closed | -$8.77M |
|
30
Lumentum
LITE
$65.2B
| – | – |
-18,850
| Closed | -$1.13M |
|
31
Invesco QQQ Trust
QQQ
$479B
| – | – |
-19,045
| Closed | -$3.54M |
|
|
SCHW
32
Charles Schwab
SCHW
$187B
| – | – |
-105,158
| Closed | -$5.17M |
|
33
Vanguard Morningstar Small-Cap ETF
VB
$81.3B
| – | – |
-21,671
| Closed | -$3.52M |
|
|
34
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| – | – |
-74,728
| Closed | -$7.16M |
|
|
35
State Street SPDR S&P Retail ETF
XRT
$323M
| – | – |
-118,897
| Closed | -$6.07M |
|
|
ACIA
36
DELISTED
Acacia Communications Inc
ACIA
| – | – |
-30,550
| Closed | -$1.26M |
|
Similar funds
CCAM
GIA
EAM
CC
BC
MIPU
WAG
VPW
Marvin & Palmer Associates's Q4 2018 Portfolio in Review
As of Q4 2018, Marvin & Palmer Associates held 36 positions worth $116M, down 12% from $132M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Marvin & Palmer Associates withdrew a net $5.49M in Q4 2018, closing 9 positions and reducing 3 holdings. Its most notable exit was iShares Core S&P Small-Cap ETF, an estimated $8.77M position sold in full.
By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Marvin & Palmer Associates opened a new position in Merck worth $5.06M.
- Marvin & Palmer Associates's largest Q4 2018 buy was Merck: 69,411 shares worth $5.06M.
- Marvin & Palmer Associates added most to Thermo Fisher Scientific in Q4 2018, an estimated $1.19M increase.
- Marvin & Palmer Associates's biggest Q4 2018 reduction was Apple, cutting an estimated $1.98M.
- Marvin & Palmer Associates fully exited iShares Core S&P Small-Cap ETF in Q4 2018, selling an estimated $8.77M.
- Marvin & Palmer Associates's ten largest holdings make up 52% of its $116M portfolio in Q4 2018.
- Marvin & Palmer Associates opened 10 new positions and closed 9 in Q4 2018.
- Marvin & Palmer Associates's portfolio value fell 12% quarter-over-quarter to $116M.
Based on Marvin & Palmer Associates's 13F filing for Q4 2018, filed 12 Feb 2019.